Table S4 from Site-Specific Dolasynthen Antibody–Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles Across a Wide Range of Drug-to-Antibody Ratios

Susan M. Clardy,Alex Uttard,Bingfan Du,Kalli C. Catcott, Kelly L. Lancaster,Elizabeth Ditty,Jack Sadowsky,Jeffrey Zurita, Naniye Malli,LiuLiang Qin, Stephen P. Bradley,Kenneth Avocetien,Tyler Carter, Dokyong Kim,Mark Nazzaro,Ling Xu,Thomas H. Pillow, Neelie T. Zacharias,Gail D. Lewis,Rebecca K. Rowntree, Radha Iyengar,David H. Lee,Marc Damelin,Dorin Toader,Timothy B. Lowinger

openalex

引用 0|浏览0
暂无评分
摘要
Table S4 compares the nominal DAR to the calculated DAR values from measured Cmax values for each ADC
更多
查看译文
关键词
Antibody Pharmacokinetics,Dosimetry
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要